A study protocol for developing a spatial vulnerability index for infectious diseases of poverty in the Caribbean region.
Kiani B. et al, (2025), Glob Health Action, 18
Understanding the initiation, formation, functioning, and performing of networks to change practices – Realist evaluation of a programme to improve newborn care in Kenya
Kalaris K. et al, (2025), SSM - Health Systems, 5, 100101 - 100101
Modelling practices, data provisioning, sharing and dissemination needs for pandemic decision-making: a European survey-based modellers' perspective, 2020 to 2022.
van Kleef E. et al, (2025), Euro Surveill, 30
Transmission dynamics of Escherichia coli sequence type 131 in households-a one health prospective cohort study.
Perez RL. et al, (2025), Nat Commun, 16
Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines.
Murray SM. et al, (2025), Sci Immunol, 10
MAIT and other innate-like T cells integrate adaptive immune responses to modulate interval-dependent reactogenicity to mRNA vaccines.
Amini A. et al, (2025), Sci Immunol, 10
Accurate measurement of viral clearance in early phase antiviral studies in COVID-19.
Wongnak P. et al, (2025), J Infect Dis
Systems approach identifies monocyte imbalance in symptomatic and asymptomatic P. vivax malaria.
Studniberg SI. et al, (2025), Mol Syst Biol
Enhancing global health security responses through greater inclusion of the global south in infectious disease modelling.
Leung K. et al, (2025), BMJ Glob Health, 10
Pathfinder studies: a novel tool for process mapping data-driven health research to build global research capacity.
Uppal A. et al, (2025), BMC Med Res Methodol, 25
Implementation of a task-shifting and task sharing intervention: A case of ward assistants in Kenyan neonatal units.
Kagonya VA. et al, (2025), Int J Nurs Stud, 171
Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages.
Kleinecke M. et al, (2025), Nat Commun, 16
A just war on bugs? Ethical differences between antimalarial resistance and antibacterial resistance.
Johnson T. et al, (2025), BMJ Glob Health, 10
Antimicrobial resistance burden landscape in Germany in 2019: a comparative country-level estimation.
Meštrović T. et al, (2025), JAC Antimicrob Resist, 7
Screening for visceral leishmaniasis in humans and animals in Laos.
Roberts T. et al, (2025), Trop Med Health, 53
Beyond evidence: How actor dynamics and power shape Knowledge Translation for Health Policy in Kenya.
Guleid FH. et al, (2025), Health Policy Plan
Systematic scoping review of the noma evidence landscape: current knowledge and gaps.
Maguire BJ. et al, (2025), BMJ Glob Health, 10